Literature DB >> 21462608

Clinical presentation & management of glomerular diseases: hematuria, nephritic & nephrotic syndrome.

Ramesh Khanna1.   

Abstract

Because the differential diagnosis for glomerulonephritis (GN) is broad, using a classification schema is helpful to narrow the causes of GN in a systematic manner. The etiology of glomerulonephritis can be classified by their clinical presentation (nephrotic, nephritic, rapidly progressive GN, chronic GN) or by histopathology. GN may be restricted to the kidney (primary glomerulonephritis) or be a secondary to a systemic disease (secondary glomerulonephritis). The nephrotic syndrome is defined by the presence of heavy proteinuria (protein excretion greater than 3.0 g/24 hours), hypoalbuminemia (less than 3.0 g/dL), and peripheral edema. Hyperlipidemia and thrombotic disease may be present. The nephritic syndrome is associated with hematuria and proteinuria and abnormal kidney function and carries poorer prognosis and is typically associated with hypertension. The predominant cause of the nephrotic syndrome in children is minimal change disease. The most common causes of nephritic syndrome are post infectious GN, IgA nephropathy and lupus nephritis. Chronic GN is slowly progressive and is associated with hypertension and gradual loss of kidney function. Treatment includes non-specific measure aimed at controlling hypertension, edema, proteinuria and disease modifying immunosuppression.

Entities:  

Mesh:

Year:  2011        PMID: 21462608      PMCID: PMC6188440     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  8 in total

Review 1.  Membranous glomerulonephritis.

Authors:  A G Wasserstein
Journal:  J Am Soc Nephrol       Date:  1997-04       Impact factor: 10.121

2.  Rapidly progressive crescentic glomerulonephritis.

Authors:  J Charles Jennette
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

Review 3.  Complications of the nephrotic syndrome and their treatment.

Authors:  R J Crew; J Radhakrishnan; G Appel
Journal:  Clin Nephrol       Date:  2004-10       Impact factor: 0.975

Review 4.  The nephrotic syndrome.

Authors:  S R Orth; E Ritz
Journal:  N Engl J Med       Date:  1998-04-23       Impact factor: 91.245

Review 5.  Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome.

Authors:  F Llach
Journal:  Kidney Int       Date:  1985-09       Impact factor: 10.612

6.  Paulista Registry of glomerulonephritis: 5-year data report.

Authors:  Patricia Malafronte; Gianna Mastroianni-Kirsztajn; Gustavo N Betônico; João Egídio Romão; Maria Almerinda R Alves; Maria Fernanda Carvalho; Osvaldo M Viera Neto; Ricardo A M Cadaval; Ronaldo R Bérgamo; Viktória Woronik; Yvoty A S Sens; Mauro S M Marrocos; Rui T Barros
Journal:  Nephrol Dial Transplant       Date:  2006-09-12       Impact factor: 5.992

7.  Changing incidence of glomerular diseases in adults.

Authors:  G L Braden; J G Mulhern; M H O'Shea; S V Nash; A A Ucci; M J Germain
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

Review 8.  The Danish Renal Biopsy Register.

Authors:  James Heaf
Journal:  Kidney Int       Date:  2004-09       Impact factor: 10.612

  8 in total
  9 in total

1.  Kidney Diseases: The Age of Molecular Markers.

Authors:  Glaucia Luciano da Veiga; Beatriz da Costa Aguiar Alves; Matheus Moreira Perez; Joyce Regina Raimundo; Jéssica Freitas de Araújo Encinas; Neif Murad; Fernando Luiz Affonso Fonseca
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Indications and considerations for kidney biopsy: an overview of clinical considerations for the non-specialist.

Authors:  Katherine L Hull; Sherna F Adenwalla; Peter Topham; Matthew P Graham-Brown
Journal:  Clin Med (Lond)       Date:  2021-12-17       Impact factor: 2.659

3.  Quantitative Mass Spectrometry Normalization in Urine Biomarker Analysis in Nephrotic Syndrome.

Authors:  Timothy D Cummins; David W Powell; Daniel W Wilkey; Makayla Brady; Fredrick W Benz; Michelle T Barati; Dawn J Caster; Jon B Klein; Michael L Merchant
Journal:  Glomerular Dis       Date:  2022-01-27

Review 4.  Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis.

Authors:  Alexandra Linke; Gisa Tiegs; Katrin Neumann
Journal:  Cells       Date:  2022-05-12       Impact factor: 7.666

5.  Association of Single Measurement of dipstick proteinuria with physical performance of military males: the CHIEF study.

Authors:  Chia-Hao Fan; Ssu-Chin Lin; Kun-Zhe Tsai; Tsung-Jui Wu; Yen-Po Lin; Yu-Kai Lin; Shao-Chi Lu; Chih-Lu Han; Gen-Min Lin
Journal:  BMC Nephrol       Date:  2020-07-18       Impact factor: 2.388

Review 6.  The Shifting Landscape of Lupus Nephritis Management: A Review.

Authors:  Adegbenga A Bankole; Jane N Nwaonu
Journal:  Cureus       Date:  2022-01-05

7.  The Importance of Toll-like Receptor 9 Expression on Monocytes and Dendritic Cells in the Context of Epstein-Barr Virus Infection in the Immunopathogenesis of Primary Glomerulonephritis.

Authors:  Iwona Smarz-Widelska; Sebastian Mertowski; Paulina Mertowska; Izabela Korona-Głowniak; Anna Hymos; Ewelina Grywalska; Wojciech Załuska
Journal:  Int J Mol Sci       Date:  2022-10-05       Impact factor: 6.208

Review 8.  PD-1 immunobiology in glomerulonephritis and renal cell carcinoma.

Authors:  Colleen S Curran; Jeffrey B Kopp
Journal:  BMC Nephrol       Date:  2021-03-06       Impact factor: 2.388

9.  YAP Translocation Precedes Cytoskeletal Rearrangement in Podocyte Stress Response: A Podometric Investigation of Diabetic Nephropathy.

Authors:  Kathryn E Haley; Mustafa Elshani; In Hwa Um; Cameron Bell; Peter D Caie; David J Harrison; Paul A Reynolds
Journal:  Front Physiol       Date:  2021-07-15       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.